This statistic compares brand drug prescription revenues of branded and unbranded generics in the United States from 2005 to 2015. In 2005, some 81 percent of total U.S. prescription revenues were made through brand name medications. However, this share decreased to some 71 percent in 2013, and increased slightly to over 74 percent in 2016. Generics are copies or equivalents of once patent protected drugs, containing the same active ingredient, in the same amount, in the same form, dissolving at the same rate in equal amounts like the original.
Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016
Exclusive Premium Statistic
This statistic compares brand drug prescription revenues of branded and unbranded generics in the United States from 2005 to 2015. In 2005, some 81 percent of total U.S. prescription revenues were made through brand name medications. However, this share decreased to some 71 percent in 2013, and increased slightly to over 74 percent in 2016. Generics are copies or equivalents of once patent protected drugs, containing the same active ingredient, in the same amount, in the same form, dissolving at the same rate in equal amounts like the original.
More information
Statistics on "Generics and biosimilars"
Popular Related Keywords
- brands
- drug
- revenue distribution
- generic drug
- sales
- Show more
- prescription
- drugs
- health
- health service
- branded products
- Pharmaceutical companies
- consumer health care
- healthcare
- generics
- consumer health products
- pharmaceutical products
- pharmaceutical regulations
- brand popularity
- pharmaceutical industry
- generics market
- generics manufacturers
- health sector
- pharmaceutical manufacturers
- retail brand share
- pharmaceutical data
- health market
- pharmaceutical business
- pharmaceutical market
- drug prescription rates
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Top generics producing companies by prescriptions dispensed 2010
- U.S. spending on specialty medicine by type 2012-2016
- U.S. spending growth on new brand specialty medicine by type 2014-2015
- U.S. spending on multiple sclerosis medicine by type 2010-2014
- U.S. spending on biosimilars by type 2014
- Number of ANDA approvals in U.S. 2015-2017, by type
- U.S. total vs. generic dispensed prescription numbers 2017, by formulation
- Generic share of dispensed prescriptions by formulation U.S. 2012 vs. 2017
- Spending on dispensed total vs. generic prescriptions in the U.S. 2017
- Average number of approved ANDAs per month in U.S. 2009-2017
- Generics prescriptions dispensed in the U.S. 2010-2016
- Sales value of the largest-selling prescription drugs sold in pharmacies Spain 2015
- Generic drug savings forecast for Canada 2015-2017
- Number of pharmaceuticals on China's national reimbursement drug list
- Generic drug cost change for Canada 2016-2018
- Deaths from drug poisoning due to psychostimulants abuse in U.S. 2005-2016
- Opinions on generic prescription medication for treatment by country 2013
- Volume share of the generic pharmaceuticals market in Switzerland 2000-2017
- Value share of generic pharmaceuticals market in Estonia 2006-2017
- Leading hair growth products in U.S. 2018
